Kensuke Mitsunari

943 total citations
68 papers, 677 citations indexed

About

Kensuke Mitsunari is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kensuke Mitsunari has authored 68 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Kensuke Mitsunari's work include Bladder and Urothelial Cancer Treatments (17 papers), Renal cell carcinoma treatment (12 papers) and Urinary Bladder and Prostate Research (8 papers). Kensuke Mitsunari is often cited by papers focused on Bladder and Urothelial Cancer Treatments (17 papers), Renal cell carcinoma treatment (12 papers) and Urinary Bladder and Prostate Research (8 papers). Kensuke Mitsunari collaborates with scholars based in Japan. Kensuke Mitsunari's co-authors include Yasuyoshi Miyata, Kojiro Ohba, Tomohiro Matsuo, Hideki Sakai, Hideki Sakai, Yasushi Mochizuki, Akihiro Asai, Shigeru Kanda, Shinichi Watanabe and Yuji Sagara and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kensuke Mitsunari

61 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kensuke Mitsunari Japan 13 289 137 117 112 103 68 677
Hye In Lee South Korea 18 307 1.1× 68 0.5× 68 0.6× 103 0.9× 120 1.2× 52 793
Wings T.Y. Loo Hong Kong 20 410 1.4× 90 0.7× 82 0.7× 240 2.1× 290 2.8× 63 1.1k
Liqun Jia China 14 305 1.1× 149 1.1× 122 1.0× 76 0.7× 155 1.5× 68 717
Valentina Pozzi Italy 26 772 2.7× 181 1.3× 89 0.8× 165 1.5× 392 3.8× 50 1.4k
Ki‐Rim Kim South Korea 17 418 1.4× 46 0.3× 43 0.4× 105 0.9× 166 1.6× 52 801
Jean‐Paul Boiteux France 16 389 1.3× 106 0.8× 112 1.0× 108 1.0× 68 0.7× 27 645
Tsung‐Ho Ying Taiwan 15 308 1.1× 37 0.3× 40 0.3× 131 1.2× 77 0.7× 45 646
Csaba Hegedűs Hungary 11 333 1.2× 63 0.5× 53 0.5× 66 0.6× 118 1.1× 20 612
Bing Zhong China 12 330 1.1× 66 0.5× 42 0.4× 90 0.8× 68 0.7× 25 614

Countries citing papers authored by Kensuke Mitsunari

Since Specialization
Citations

This map shows the geographic impact of Kensuke Mitsunari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Mitsunari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Mitsunari more than expected).

Fields of papers citing papers by Kensuke Mitsunari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Mitsunari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Mitsunari. The network helps show where Kensuke Mitsunari may publish in the future.

Co-authorship network of co-authors of Kensuke Mitsunari

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Mitsunari. A scholar is included among the top collaborators of Kensuke Mitsunari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Mitsunari. Kensuke Mitsunari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mochizuki, Yasushi, et al.. (2025). Spontaneous Rupture of Adrenal Myelolipoma: A Case Report With Review of the Literature. IJU Case Reports. 8(3). 253–256.
2.
Matsuo, Tomohiro, et al.. (2025). Efficacy of Pembrolizumab as Second or Third-line Therapy for Local Advanced and Metastatic Urothelial Cancer. Anticancer Research. 45(6). 2563–2573. 1 indexed citations
3.
Mitsunari, Kensuke, et al.. (2024). Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy. Anticancer Research. 44(7). 3149–3154. 4 indexed citations
5.
Mitsunari, Kensuke, et al.. (2024). Prognostic Predictors of Hypertension Outcomes After Adrenalectomy in Primary Aldosteronism. In Vivo. 38(6). 2729–2734.
6.
Mitsunari, Kensuke, Shota Yamada, Hidenori Ito, et al.. (2023). Partial penectomy for severe penile ulceration caused by cholesterol crystal embolization. IJU Case Reports. 6(6). 394–397. 1 indexed citations
7.
Matsuo, Tomohiro, et al.. (2023). Evans syndrome during pembrolizumab therapy for upper urinary tract cancer. IJU Case Reports. 6(5). 298–301. 1 indexed citations
8.
Ohba, Kojiro, Kensuke Mitsunari, Hiromi Nakanishi, et al.. (2023). Initial experience in robot-associated radical nephrectomy with inferior vena cava tumor thrombectomy. Translational Cancer Research. 12(12). 3425–3431. 1 indexed citations
9.
Mitsunari, Kensuke, et al.. (2022). Pathological Significance of Kidney and Brain Expressed Protein (KIBRA) in Clear Cell Renal Cell Carcinoma. Anticancer Research. 43(1). 45–51.
10.
Ohba, Kojiro, Yasuyoshi Miyata, Kensuke Mitsunari, et al.. (2022). Alternative Treatment with Every-Other-Day Dosing of Sunitinib for Metastatic Renal Cell Carcinoma: Extended Follow-Up. Urologia Internationalis. 106(6). 623–629. 1 indexed citations
11.
Ohba, Kojiro, Kensuke Mitsunari, Yoshiko Hayashida, et al.. (2021). A randomized clinical trial of intravesical instillation of MMC and combination of MMC and Ara-C in non-muscle invasive bladder cancer. European Urology. 79. S1057–S1057.
12.
Miyata, Yasuyoshi, Tsuyoshi Matsuda, Kensuke Mitsunari, et al.. (2021). Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. In Vivo. 35(3). 1693–1701. 5 indexed citations
13.
Matsuo, Tomohiro, et al.. (2021). Efficacy of salt reduction for managing overactive bladder symptoms: a prospective study in patients with excessive daily salt intake. Scientific Reports. 11(1). 4046–4046. 5 indexed citations
14.
Miyata, Yasuyoshi, Hidenori Ito, Kensuke Mitsunari, et al.. (2021). Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model. Scientific Reports. 11(1). 20279–20279. 7 indexed citations
15.
Miyata, Yasuyoshi, Tomohiro Matsuo, Kensuke Mitsunari, et al.. (2020). Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate Cancer. Anticancer Research. 40(10). 5567–5575. 7 indexed citations
16.
Mitsunari, Kensuke, et al.. (2016). Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival. Oncology Letters. 13(2). 834–840. 6 indexed citations
18.
Matsuo, Tomohiro, et al.. (2015). Effects of daily salt intake on urinary symptoms: a comparison between patients with hypertension and normal blood pressure. Neurourology and Urodynamics. 1 indexed citations
19.
Miyata, Yasuyoshi, et al.. (2014). Smoking-induced changes in cancer-related factors in patients with upper tract urothelial cancer. Molecular and Clinical Oncology. 3(2). 287–294. 10 indexed citations
20.
Ohba, Kojiro, Yasuyoshi Miyata, Kensuke Mitsunari, et al.. (2014). Left atrial metastasis of renal cell carcinoma: a case report and review of the literature. BMC Research Notes. 7(1). 520–520. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026